Skip to content

Clinical observation on the application of remazolam tosylate in painless abortion: a randomized controlled trial.

Clinical observation on the application of remazolam tosylate for injection in painless abortion

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034429
Enrollment
Unknown
Registered
2020-07-05
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless abortion surgery

Interventions

Sponsors

Xinxiang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 100 non-hospitalized 18-35-year-old female patients undergoing painless abortion surgery in our hospital at selected time: 1. 6-8 weeks of pregnancy, no history of vaginal delivery; 2. Patients who voluntarily conduct painless abortion; 3. The ASA grade is I-II; 4. BMI18-30kg/m2.

Exclusion criteria

Exclusion criteria: 1. Difficult airway such as Mallampati score 3 or 4; 2. Lactating women; 3. Have obvious heart, lung, liver, kidney and metabolic diseases; 4. Those who have acute inflammation of the respiratory tract and have not been cured within the past 2 weeks; 5. Suspected abuse of narcotic analgesics; 6. Those with neuromuscular disease or mental illness; 7. Patients who are known to be allergic to emulsions and opioids; 8. In the past three months or currently participating in other research.

Design outcomes

Primary

MeasureTime frame
MAP;HR;SpO2;RR;BIS;modified observer's assessment of alert /sedation;Adverse reactions;Patient satisfaction;Surgeon satisfaction;

Countries

China

Contacts

Public ContactWang Lihua

Xinxiang Central Hospital

wlhqueen@163.com+86 15036636986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026